Oral anticoagulant persistence in patients with non-valvular atrial fibrillation: A cohort study using primary care data in Germany
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oral anticoagulant persistence in patients with non-valvular atrial fibrillation: A cohort study using primary care data in Germany
Authors
Keywords
Hemorrhage, Primary care, Ischemic stroke, Physicians, Antiplatelet therapy, Atrial fibrillation, German people, Health risk analysis
Journal
PLoS One
Volume 12, Issue 10, Pages e0185642
Publisher
Public Library of Science (PLoS)
Online
2017-10-11
DOI
10.1371/journal.pone.0185642
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Health Care Resource Utilization, Costs, and Persistence in Patients Newly Diagnosed as Having Nonvalvular Atrial Fibrillation and Newly Treated With Dabigatran versus Warfarin in the United States
- (2016) Tim Bancroft et al. CLINICAL THERAPEUTICS
- Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation
- (2016) Jan Beyer-Westendorf et al. EUROPACE
- Major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a “real-world” observational study in the United States
- (2016) Gregory Y. H. Lip et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- CHANGES OVER TIME IN TREATMENT PERSISTENCE OF ORAL ANTICOAGULANTS IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
- (2016) Cinira Lefevre et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Early real-world evidence of persistence on oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a cohort study in UK primary care
- (2016) Michelle E Johnson et al. BMJ Open
- Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation
- (2016) Joshua D. Brown et al. Journal of Managed Care & Specialty Pharmacy
- Treatment Persistence and Discontinuation with Rivaroxaban, Dabigatran, and Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in the United States
- (2016) Craig I. Coleman et al. PLoS One
- Adherence to and persistence with non-vitamin K-antagonist oral anticoagulants: does the number of pills per day matter?
- (2015) Andrea Rubboli CURRENT MEDICAL RESEARCH AND OPINION
- Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice: barriers to and strategies for optimal implementation
- (2015) A. John Camm et al. EUROPACE
- Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation
- (2015) Tomas Forslund et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
- (2014) Emily C. O’Brien et al. AMERICAN HEART JOURNAL
- Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naive atrial fibrillation patients: Danish nationwide descriptive data 2011-2013
- (2014) J. B. Olesen et al. EUROPACE
- REAL WORLD DISCONTINUATION RATES WITH APIXABAN VERSUS WARFARIN, DABIGATRAN, OR RIVAROXABAN AMONG ATRIAL FIBRILLATION PATIENTS NEWLY INITIATED ON ANTICOAGULATION THERAPY: EARLY FINDINGS
- (2014) Xianying Pan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Worldwide Epidemiology of Atrial Fibrillation
- (2013) Sumeet S. Chugh et al. CIRCULATION
- Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin
- (2013) Martin Zalesak et al.
- Practical Considerations for Using Novel Oral Anticoagulants in Patients With Atrial Fibrillation
- (2013) Irene Savelieva et al. CLINICAL CARDIOLOGY
- Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke
- (2013) J. P. Piccini et al. EUROPEAN HEART JOURNAL
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) Versus Warfarin in Patients With Atrial Fibrillation
- (2012) Corey S. Miller et al. AMERICAN JOURNAL OF CARDIOLOGY
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPEAN HEART JOURNAL
- Validity and representativeness of the “Disease Analyzer” patient database for use in pharmaco-epidemiological and pharmacoeconomic studies
- (2011) H. Becher et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Warfarin Discontinuation After Starting Warfarin for Atrial Fibrillation
- (2010) Margaret C. Fang et al.
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More